BioAdaptives, Inc.
corporate_fare Company Profile
BioAdaptives, Inc. (OTC:BDPT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for BDPT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for BDPT spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- BioAdaptives Q3: $5,144 Cash, Going-Concern Doubt, 223.7M Shares After Debt Conversions
- Penny-Stock Nutraceutical Firm Buys Preclinical Psilocybin Biotech With Stock, No Cash
- BioAdaptives to Acquire Xycota; Founders Get 40% Economics and Eventual 51% Voting Control
- BioAdaptives Q2 10-Q: Going Concern, Cash Crunch, and Massive Dilution from Debt Conversions
- BioAdaptives' MyndSystem™ Achieves Full WADA Compliance, Unlocking Pro Athlete Market
Financial Snapshot
Short Interest & Short Volume
On November 20, 2026, 98.8% of BDPT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.